Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Inbi Appoints Anat Cohen Dayag As Chief Executive Officer
PRIVATESep 08, 2026•about 3 hours ago
Position
Chief Executive Officer
Company
Israel National Biotech Innovation Center (INBI)
Anat Cohen-Dayag
Tel AvivBiotechnologyTherapeutics
Description
The Israel National Biotech Innovation Center (INBI) announced the appointment of Anat Cohen-Dayag, PhD, as Chief Executive Officer of INBI Core Ltd. The announcement comes as part of the official launch of its activities, aiming to bridge the gap between academic discovery and clinical application.
Company Information
Company
Israel National Biotech Innovation Center (INBI)
Location
Tel Aviv, Tel Aviv District, Israel
About
INBI is a transformational hub designed to unlock the value of Israel's world-class biomedical research and accelerate the development of breakthrough therapeutics. INBI is a non-profit, national center of excellence with a mission to advance Israel's disruptive academic research into breakthrough therapeutics. Powered by a network of global industry leaders, INBI will build a world-class team with expertise in early-stage drug development.
Don't miss Israel National Biotech Innovation Center (INBI)'s next move
Get an email the moment Israel National Biotech Innovation Center (INBI) changes its leadership, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Israel National Biotech Innovation Center (INBI)'s next move
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months
Israel National Biotech Innovation Center (INBI) changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
Tel AvivBiotechnologyTherapeutics